Patent details

Basic Information

Publication number:

EP1736158

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP060172319

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Use of 1- 4-(5-cyanoindol-3-yl)butyl -4-(2-carbamoylbenzofuran-5-yl)piperazine and its physiologically acceptable salts

French Title of Invention:

Utilisation de la 1- 4-(5-cyanoindol-3-yl)butyl -4-(2-carbamoylbenzofuran-5-yl)piperazine et de ses sels physiologiquement acceptables

German Title of Invention:

Verwendung von 1- 4-(5-cyanoindol-3-yl)butyl -4-(2-carbamoylbenzofuran-5-yl)piperazin und dessem physiologisch akzeptablen Salzen

SPC Number:

Dates

Filing date:

16/05/2000

Grant date:

05/08/2009

EP Publication Date:

05/08/2009

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

27/12/2006

EP B1 Publication Date:

05/08/2009

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

16/05/2011

Expiration date:

16/05/2020

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

16/05/2000

 

 

Name:

Merck Patent GmbH

Address:

Frankfurter Strasse 250, 64293 Darmstadt, Germany (DE)

Inventor

1

Name:

van Amsterdam Christoph

Address:

Germany (DE)

2

Name:

Bartoszyk Gerd

Address:

Germany (DE)

3

Name:

Seyfried Christoph

Address:

Germany (DE)

4

Name:

Boettcher Henning

Address:

Germany (DE)

5

Name:

Sedman Ewen

Address:

United Kingdom (GB)

Priority

Priority Number:

99109295

Priority Date:

27/05/1999

Priority Country:

European Patent Office (EPO) (EP)

Classification

Main IPC Class:

A61K 31/495;

Filing date	Document type	Number of pages